ad image

IND

1 / 1
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
IND Enablement

IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"

Johannes Clemens

Coriolis Pharma

PAO-08-24-CL-07Aug 16, 2024
Model Medicines
COVID-19 Antiviral

Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)

Model Medicines

PR-M02-22-05Feb 08, 2022
Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site
Industry Leader Insight

Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site

Magnus Schroeder, Ph.D.

Avid Bioservices

PAP-Q2-20-CL-002Jul 01, 2020
Cellectis
Allogeneic CAR-T

FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients

Cellectis

PR-M04-19-NI-028Apr 09, 2019
GC Biopharma
Vaccine

Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate

GC Biopharma

PR-M11-18-NI-024Nov 07, 2018
Coordination Pharmaceuticals, Inc.
FDA Approval

FDA Grants Coordination Pharmaceuticals IND Approval for CPI-100, a Novel Antitumor Nanomedicine

Coordination Pharmaceuticals, Inc.

PR-M10-18-NI-031Oct 10, 2018
WuXi Biologics to Supply Antibody Drugs for Adagene, Inc.
Strategic Collaboration

WuXi Biologics to Supply Antibody Drugs for Adagene, Inc.

Guy Tiene

Nice Insight

PAO-M03-18-NI-014Mar 15, 2018
First Treatment for Rare Blood Disorder Approved by FDA
FDA

First Treatment for Rare Blood Disorder Approved by FDA

Nice Insight

PAO-M11-17-NI-026Nov 16, 2017
FDA Accepts VBI Vaccines’ IND to Treat Glioblastoma Multiforme
IND

FDA Accepts VBI Vaccines’ IND to Treat Glioblastoma Multiforme

Guy Tiene

Nice Insight

PAO-M08-17-NI-028Aug 22, 2017
Shire Submits IND for Hemophilia A Gene Therapy
Cell and Gene Therapy

Shire Submits IND for Hemophilia A Gene Therapy

Nigel Walker

Nice Insight

PAO-M07-17-NI-016Jul 13, 2017
How a CMO Can Help With Investigational New Drug Applications

How a CMO Can Help With Investigational New Drug Applications

Stephen A. Munk, Ph.D

Ash Stevens

PAP-APR-S01-CL-002Apr 01, 2015
1 / 1